Detailed price information for Sana Biotechnology Inc (SANA-Q) from The Globe and Mail including charting and trades.

Serina Therapeutics, Inc. ('Serina” or the 'Company') (NYSE American: SER), a clinical-stage biotechnology company advancing its lead Investigational New Drug ('IND') candidate, SER-252, for advanced ...

US pharma major Bristol Myers Squibb has announced progress for its multi-indication cancer drug Opdivo (nivolumab) in ...

Bartronics India Limited has marked a significant milestone in its growth trajectory with the approval and incorporation of ...

Final 2025 global cohort onboarding, with applications now open for 2026WILMINGTON, Mass.--(BUSINESS WIRE)--$CRL #CDMO--Charles River Laboratories International, Inc. (NYSE: CRL) today announced the ...

NewcelX ( ($NCEL) ) has issued an announcement. On December 11, 2025, NewcelX Ltd. announced the publication of a patent application in China for ...

This is the third of four planned U.S. manufacturing sites the pharmaceutical giant has unveiled this year, set to bring 450 ...

Locus Fermentation Solutions of Solon said it has closed an early-stage fundraising round, bringing the business's total ...

PREVIOUS COVERAGE - Pharmaceutical giant Eli Lilly and Company announced Tuesday a massive $6 billion investment to build a ...

Researchers at McMaster University have developed a rapid and inexpensive method to produce “mechanically robust” cell sheets ...

The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

NewcelX Ltd. (Nasdaq: NCEL), a next-generation biotechnology company developing advanced cell-therapy and neuroscience-driven ...